| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| JNCE | Jounce Therapeutics, Inc. | Duncan Barbara Gayle | Director | Sep 15, 2020 | Sale | $7.11 | 20,000 | 142,100 | 10,000 | Sep 16, 2020, 06:43 PM | |
| IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Sep 14, 2020 | Option Exercise | $16.96 | 2,500 | 42,400 | 39,577 | Sep 15, 2020, 04:30 PM | |
| IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Aug 17, 2020 | Option Exercise | $16.96 | 20,000 | 339,200 | 37,077 | Aug 20, 2020, 04:15 PM | |
| IMMU | IMMUNOMEDICS INC | Duncan Barbara Gayle | Director | Aug 12, 2020 | Option Exercise | $12.93 | 17,077 | 220,806 | 17,077 | Aug 14, 2020, 04:33 PM | |
| JNCE | Jounce Therapeutics, Inc. | Duncan Barbara Gayle | Director | Mar 15, 2018 | Option Exercise | $16.16 | 4,000 | 64,640 | 2,000 | Mar 19, 2018, 06:42 PM | |
| JNCE | Jounce Therapeutics, Inc. | Duncan Barbara Gayle | Director | Jan 26, 2018 | Option Exercise | $14.61 | 8,000 | 116,840 | 4,000 | Jan 29, 2018, 08:26 PM | |
| GNMX | Aevi Genomic Medicine, Inc. | Duncan Barbara Gayle | Director | Oct 17, 2017 | Buy | $1.26 | 59,524 | 75,000 | 59,524 | Oct 18, 2017, 04:16 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Accounting Officer | Oct 03, 2016 | Sale | $163.20 | 147 | 23,990 | 30,661 | Oct 05, 2016, 09:04 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Accounting Officer | Jul 05, 2016 | Sale | $145.11 | 146 | 21,186 | 30,808 | Jul 07, 2016, 09:03 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Apr 04, 2016 | Sale | $130.76 | 144 | 18,829 | 30,948 | Apr 06, 2016, 09:00 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jan 04, 2016 | Sale | $145.90 | 468 | 68,283 | 25,320 | Jan 05, 2016, 09:00 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Oct 01, 2015 | Option Exercise | $86.03 | 2,000 | 172,057 | 24,116 | Oct 05, 2015, 09:02 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Oct 02, 2015 | Sale | $159.04 | 54 | 8,588 | 24,062 | Oct 05, 2015, 09:02 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jul 02, 2015 | Sale | $236.26 | 53 | 12,522 | 18,771 | Jul 07, 2015, 09:00 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jul 01, 2015 | Sale | $125.38 | 2,000 | 250,767 | 18,523 | Jul 06, 2015, 09:00 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Apr 02, 2015 | Sale | $277.70 | 39 | 10,830 | 17,523 | Apr 03, 2015, 09:01 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Mar 27, 2015 | Sale | $289.82 | 1,000 | 289,817 | 17,164 | Apr 01, 2015, 10:00 AM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jan 05, 2015 | Sale | $176.49 | 141 | 24,885 | 17,264 | Jan 07, 2015, 09:00 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jan 02, 2015 | Sale | $94.15 | 2,000 | 188,300 | 18,405 | Jan 05, 2015, 09:00 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Oct 01, 2014 | Sale | $132.51 | 2,000 | 265,019 | 17,107 | Oct 03, 2014, 09:01 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Apr 14, 2014 | Option Exercise | $150.25 | 2,308 | 346,777 | 14,664 | Apr 15, 2014, 09:01 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jan 15, 2014 | Sale | $145.54 | 11,250 | 1,637,352 | 16,333 | Jan 17, 2014, 09:01 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jul 08, 2013 | Option Exercise | $27.61 | 50,000 | 1,380,398 | 33,112 | Jul 10, 2013, 09:33 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Jun 19, 2013 | Option Exercise | $22.06 | 101,150 | 2,231,712 | 56,759 | Jun 21, 2013, 09:30 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | May 23, 2013 | Option Exercise | $21.60 | 220 | 4,753 | 6,924 | May 28, 2013, 09:30 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | May 24, 2013 | Option Exercise | $21.58 | 2,400 | 51,800 | 8,014 | May 28, 2013, 09:30 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | May 28, 2013 | Sale | $21.58 | 9,830 | 212,164 | 11,729 | May 28, 2013, 09:30 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | May 20, 2013 | Sale | $22.57 | 56,400 | 1,272,831 | 35,014 | May 22, 2013, 09:30 PM | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | Duncan Barbara Gayle | Chief Financial Officer | Apr 09, 2013 | Option Exercise | $34.57 | 2,676 | 92,509 | 3,814 | Apr 11, 2013, 09:36 PM |
Menu